Uptake, impact, and effectiveness of rotavirus vaccination in the United States: Review of the first 3 years of postlicensure data

Pediatric Infectious Disease Journal

Volumn 30, Issue SUPPL. 1, 2011, Pages

  Tate, Jacqueline E ^a   Cortese, Margaret M ^a   Payne, Daniel C ^a   Curns, Aaron T ^a   Yen, Catherine ^a   Esposito, Douglas H ^a   Cortes, Jennifer E ^a   Lopman, Benjamin A ^a   Patel, Manish M ^a   Gentsch, Jon R ^a   Parashar, Umesh D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

rotavirus; rotavirus vaccine; vaccine impact

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; DRUG EFFICACY; EMERGENCY WARD; GASTROENTERITIS; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; OUTPATIENT; PATIENT COMPLIANCE; PEDIATRICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; UNITED STATES; VACCINATION;

AMBULATORY CARE; EMERGENCY MEDICAL SERVICES; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEASONS; UNITED STATES; VACCINATION;

EID: 78751485166     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181fefdc0     Document Type: Article

References (33)

1. Charles MD, Holman RC, Curns AT, et al. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J. 2006;25:489-493.
2. Jin S, Kilgore PE, Holman RC, et al. Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J. 1996;15:397-404.
3. Malek MA, Curns AT, Holman RC, et al. Diarrhea-and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117:1887-1892.
4. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122:1235-1243.
5. Fischer TK, Viboud C, Parashar U, et al. Hospitalizations and deaths from diarrhea and rotavirus among children 5 years of age in the United States, 1993-2003 J Infect Dis 2007,195, 1117-1125.
6. Kilgore PE, Holman RC, Clarke MJ, et al. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA. 1995;274: 1143-1148.
7. Widdowson MA, Meltzer MI, Zhang X, et al. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007;119:684-697.
8. Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55(RR-12):1-13.
9. Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25.
10. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. Morb Mortal Wkly Rep. 1999;48:577-581.
11. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572.
12. Kempe A, Patel MM, Daley MF, et al. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States. Pediatrics. 2009;124:e809-e816.
13. Jacobson LM, Santosham M, Milstone AM. Pediatric providers' acceptance of recommendations for routine rotavirus vaccination. Clin Pediatr (Phila).2008;47:500-503.
14. Kempe A, Daley MF, Parashar UD, et al. Will pediatricians adopt the new rotavirus vaccine? Pediatrics. 2007;119:1-10.
15. Patel MM, Janssen AP, Tardif RR, et al. A qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers. BMC Pediatr. 2007;7:32.
16. Loughlin J, Wang FT, El Khoury A, et al. Adherence to the recommended pentavalent rotavirus vaccine administration schedule in the United States: 2006-2007. Pediatr Infect Dis J. 2009;28:667-668.
17. Daskalaki I, Spain CV, Long SS, et al. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use. Pediatrics. 2008;122:e33-e38.
18. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule-United States, February 2006-May 2007. Morb Mortal Wkly Rep. 2008; 57:398-401.
19. Rotavirus vaccination coverage among infants aged 5 months -immunization information system sentinel sites, United States, June 2006-June 2009. Morb Mortal Wkly Rep. 2010;59:521-524.
20. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. (Pubitemid 43048948)
21. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
22. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007; 370:1757-1763.
23. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207.
24. Wang FT, Mast TC, Glass RJ, et al. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010;125:e208-e213.
25. Tate JE, Panozzo CA, Payne DC, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009;124:465-471.
26. Reduction in rotavirus after vaccine introduction-United States, 2000-2009. Morb Mortal Wkly Rep. 2009;58:1146-1149.
27. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. Morb Mortal Wkly Rep. 2008;57:697-700.
28. Curns AT, Steiner CA, Barrett M, et al. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis. 2010;201:1617-1624.
29. Pitzer VE, Viboud C, Simonsen L, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science. 2009;325:290-294.
30. Begue RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics. 2010; 126:e40-e45.
31. Cortese MM, Tate JE, Simonsen L, et al. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J. 2010;29:489-494.
32. Curns AT, Coffin F, Glasser JW, et al. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children 5 years of age during 2006-2015 J Infect Dis 2009, 200, SUPPL. 1, S49-S56.
33. FDA. Update on recommendations for the use of rotavirus vaccines. Cited May 20, 2010. Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ ApprovedProducts/ucm212140.htm.